IP Library › Granted Patent US 8,575,230
Granted Patent B2
US 8,575,230 · App. 12/595,997 · Granted Nov 5, 2013

Environment-friendly antifoulants for the prevention of biofouling

Inventors: John A. Schetz (Fort Worth, TX); Robert F. McMahon (Arlington, TX)
Assignees: University of North Texas Health Science Center at Fort Worth; The Board of Regents of the University of Texas System
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,575,230
App. No.
12/595,997
Granted
Nov 5, 2013
Kind
B2
Abstract

Environmentally-friendly alternatives to organometallic antifoulants that are efficacious at preventing biofouling by organisms such as the zebra mussel. Preferred antifoulant compositions utilize compounds having a Lipophilic-Amide-Spacer-ElectroNegative (“LASEN”) structural motif, such as capsaicin, and compounds having a TetraHydroCannibinoid (“THC”) structural motif. The antifoulant compositions are non-toxic, and effective.

Claims (23)

1. A method of reducing aquatic biofouling on a surface comprising:

adding an antifoulant compound to the aquatic environment in contact with the surface, wherein the antifoulant compound comprises:

(a) anandamide, having the structure:

(b) N-benzoylmonoethanolamine benzoate, having the structure:

(c) N-(1-(hydroxymethyl)propyl)decanamide, having the structure:

(d) Linoleyl ethanolamide, having the structure:

(e) N-(2-(2-(3,4-dimethoxybenzylidene)hydrazine)-2-oxoethyl)dodecanamide, having the structure:

(f) O-2050, having the structure:

(g) CP55,940, having the structure:

(h) Noladin ether, having the structure:

(i) AM630, having the structure:

2. A method of reducing aquatic biofouling on a surface, comprising:

contacting an antifoulant compound with the surface,

wherein the antifoulant compound comprises:

(a) anandamide, having the structure:

(b) N-benzoylmonoethanolamine benzoate, having the structure:

(c) N-(1-(hydroxymethyl)propyl)decanamide, having the structure:

(d) Linoleyl ethanolamide, having the structure:

(e) N-(2-(2-(3,4-dimethoxybenzylidene)hydrazine)-2-oxoethyl)dodecanamide, having the structure:

(f) O-2050, having the structure:

(g) CP55,940, having the structure:

(h) Noladin ether, having the structure:

(i) AM630, having the structure:

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2010
From: MCMAHON, ROBERT F.
To: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 024508/0986 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2010
From: SCHETZ, JOHN A.
To: UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER AT FORT WORTH
Reel/Frame 024509/0282 →
Continuity (2)
Provisional Application 60925260 · Apr 19, 2007
Related Publication 20100256256A1 · Oct 7, 2010